The influence of glycosylation on secretion, stability, and immunogenicity of recombinant HBV pre-S antigen synthesized in Saccharomyces cerevisiae

Biochemical and Biophysical Research Communications

Volumn 303, Issue 2, 2003, Pages 427-432

  Lee, Jeewon ^a   Park, Jin Seung ^a   Moon, Je Young ^b   Kim, Ki Yong ^b   Moon, Hong Mo ^b  

^a Korea University   (South Korea)

^b Dobeel Corp   (South Korea)

Author keywords

HBV pre S; Immunogenicity; N glycosylation; Proteolysis; Secretion

Indexed keywords

GLYCAN DERIVATIVE; MEMBRANE ANTIGEN; NEUTRALIZING ANTIBODY; PROTEINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GLYCOSYLATION; HEPATITIS B VIRUS; IMMUNOGENICITY; KLUYVEROMYCES; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN STABILITY; SACCHAROMYCES CEREVISIAE; SURFACE PROPERTY; WILD TYPE;

HEPATITIS B VIRUS; KLUYVEROMYCES; KLUYVEROMYCES LACTIS; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0037418742     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00351-6     Document Type: Article

References (22)

1. Neurath A.R., Kent S.B.H. The pre-S region of hepadnavirus envelope proteins. Adv. Virus Res. 34:1988;65-142.
2. Gerlich W.H., Deepen R., Heermann K.-H., Krone B., Lu X.-Y., Seifer M., Thomssen R. Protective potential of hepatitis B virus antigens other than the S gene protein. Vaccine. 8(Suppl):1990;S63-S68.
3. Milich D.R., Thornton G.B., Neurath A.R., Kent S.B., Michel M.L., Tiollais P., Chisari F.V. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science. 228:1985;1195-1199.
4. Shouval D., Ilan Y., Adler R., Deepen R., Panet A., Even-Chen Z., Gorecki M., Gerlich W.H. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines. Vaccine. 12:1994;1453-1459.
5. Neurath A.R., Kent S.B.H., Strick N., Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell. 46:1986;429-436.
6. Neurath A.R., Seto B., Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus envelope protein are virus-neutralizing and protective. Vaccine. 7:1989;234-236.
7. Jones C.D., Page M., Bacon A., Cahill E., Bentley M., Chatfield S.N. T-cell and antibody response characterization of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice. Vaccine. 17:1999;2528-2537.
8. Page M., Jones C.D., Bailey C. A novel, recombinant triple antigen hepatitis B vaccine (Hepacare). Intervirology. 44:2001;88-97.
9. Romanos M.A., Score C.A., Clare J.J. Foreign gene expression in yeast: a review. Yeast. 8:1992;423-488.
10. Bae C.S., Yang D.S., Jang K.R., Seong B.L., Lee J. Enhanced secretion of human granulocyte colony-stimulating factor directed by a novel hybrid fusion peptide from recombinant Saccharomyces cerevisiae at high cell concentration. Biotechnol. Bioeng. 57:1998;600-609.
11. Lee J., Choi S.I., Jang J.S., Jang K.R., Moon J.W., Bae C.S., Yang D.S., Seong B.L. Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1β as secretion enhancer. Biotechnol. Prog. 15:1999;884-890.
12. Baldari C., Murray J.A., Ghiara P., Cesareni G., Galeotti C.L. A novel leader peptide which allows efficient secretion of a fragment human interleukin 1 β in Saccharomyces cerevisiae. EMBO J. 6:1987;229-234.
13. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. second ed. 1989;Cold Spring Harbor Laboratory Press, New York.
14. Starcich B.R., Hahn B.H., Shaw G.M. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV the retrovirus of AIDS. Cell. 45:1986;637-648.
15. Bolmstedt A., Hinkula J., Rowcliffe E., Biller M., Wahren B., Olofsson S. Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals effects of elimination of the V3 N306 glycan. Vaccine. 20:2002;397-405.
16. Doyon Y., Home W., Daull P., LeBel D. Effect of C-domain N-glycosylation and deletion on rat pancreatic α-amylase secretion and activity. Biochem. J. 362:2002;259-264.
17. Eriksen S.H., Jensen B., Olsen J. Effect of N-linked glycosylation on secretion activity and stability of α-amylase from Aspergillus oryzae. Curr. Microbiol. 37:1998;117-122.
18. Zhu A., Wang Z.K., Beavis R. Structural studies of α-N-acetylgalactosaminidase: effect of glycosylation on the level of expression, secretion efficiency and enzyme activity. Arch. Biochem. Biophys. 352:1998;1-8.
19. Rothwell V., Kosowski S., Hadjilambris O., Baska R., Norman J. Glycosylation of active human rennin is necessary for secretion: effect of targeted modifications of Asn-5 and Asn-75. DNA Cell Biol. 12:1993;291-298.
20. Livi G.P., Lillquist J.S., Miles L.M., Ferrara A., Sathe G.M., Simon P.L., Meyers C.A., Gorman J.A., Young P.R. Secretion of N-glycosylated interleukin-1β in Saccharomyces cerevisiae using a leader peptide from Candida albicans. Effect of N-linked glycosylation on biological activity. J. Biol. Chem. 266:1991;15348-15355.
21. Pratap J., Rajamohan G., Dikshit K.L. Characteristics of glycosylated streptokinase secreted from Pichia pastoris: enhanced resistance of SK to proteolysis by glycosylation. Appl. Microbiol. Biotechnol. 53:2000;469-475.
22. Gahring L., Carlson N.G., Meyer E.L., Rogers S.W. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J. Immunol. 166:2001;1433-1438.